Radiopharmaceuticals based on neurokinin-1 receptor antagonists for the diagnosis and therapy of a brain tumour - glioblastoma multiforme.

2017/25/B/NZ7/01896

Keywords

Descriptors

  • NZ7_14: Farmacja, farmakoterapia, farmakologia
  • ST5_16: Chemia biologiczna
  • ST4_16: Chemia jądrowa i radiacyjna

Panel

NZ7 – Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology

Host institution

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Voivodeship: mazowieckie

Other projects carried out by the institution »

Principal investigator (from the host institution)

prof. Aleksandra Misicka-Kęsik

Number of co-investigators in the project: 9

Call

OPUS 13 – announced on 2017-03-15

Amount awarded
961 230 PLN
Project start date
2018-02-15
Project end date
2022-02-14
Project duration
48 months (the same as in the proposal)
Project status
Project settled

Project description

Download the project description in a pdf file

Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Equipment purchased [PL]

  1. Homogenizator. Cost: 6 000 PLN
  2. Mikrowirówka.
  3. Myjka ultradźwiękowa. Cost: 3 600 PLN
  4. Nowoczesny komputer z akcesoriami. Cost: 13 000 PLN
  5. Pompa strzykawka ze sterownikiem.
  6. Stacja wodna. Cost: 10 776 PLN
  7. Suchy blok grzejny (termoblok). Cost: 6 000 PLN
  8. Urządzenie filtracyjne do płytek 96-dołkowych z oprzyrządowaniem. Cost: 76 000 PLN
  9. Vortex z akcesoriami. Cost: 3 400 PLN
  10. Wirnik (rotor) do wirówki. Cost: 8 000 PLN
  11. Wirówka laboratoryjna z wymiennymi rotorami. Cost: 30 000 PLN
  12. Zbiornik na ciekły azot (Dewar).

Information in the final report

Publication in academic press/journals (5)

  1. The Significance of NK1 Receptor Ligands and Their Application in Targeted Radionuclide Tumour Therapy

    Authors:
    Agnieszka Majkowska-Pilip, Paweł Krzysztof Halik, Ewa Gniazdowska
    Academic press:
    Pharmaceutics (year: 2019, volume: 11, pages: 443), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/pharmaceutics11090443 – link to the publication
  2. Novel NK1R-Targeted 68Ga-/177Lu-Radioconjugates with Potential Application against Glioblastoma Multiforme: Preliminary Exploration of Structure–Activity Relationships

    Authors:
    Joanna Matalińska, Katarzyna Kosińska, Paweł K. Halik, Przemysław Koźmiński, Piotr F. J. Lipiński, Ewa Gniazdowska, Aleksandra Misicka
    Academic press:
    International Journal of Molecular Sciences (year: 2022, volume: 23, pages: 1214), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/ijms23031214 – link to the publication
  3. Application of Neurokinin-1 Receptor in Targeted Strategies for Glioma Treatment. Part I: Synthesis and Evaluation of Substance P Fragments Labeled with 99mTc and 177Lu as Potential Receptor Radiopharmaceuticals

    Authors:
    Agnieszka Majkowska-Pilip, Przemysław Koźmiński, Anna Wawrzynowska, Tadeusz Budlewski, Bogusław Kostkiewicz, Ewa Gniazdowska
    Academic press:
    Molecules (year: 2018, volume: 23, pages: 2542), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/molecules23102542 – link to the publication
  4. In Vitro Biological Evaluation of Aprepitant Based 177Lu-Radioconjugates

    Authors:
    Halik, P.; Koźmiński, P.; Matalińska, J.; Lipiński, P.F.J.; Misicka, A.; Gniazdowska, E.
    Academic press:
    Pharmaceutics (year: 2022, volume: 14, pages: 607), Publisher: MDPI
    Status:
    Published
    DOI:
    10.3390/pharmaceutics14030607 – link to the publication
  5. Radiochemical Synthesis and Evaluation of Novel Radioconjugates of Neurokinin 1 Receptor Antagonist Aprepitant Dedicated for NK1R-Positive Tumors

    Authors:
    Halik, P. K.; Lipiński, P.F.J.; Matalińska, J.; Koźmiński, P.; Misicka, A.; Gniazdowska E.
    Status:
    Accepted for publication

« New search

Graphic design and implementation: Jakub Piotrowski